VERAXA Biotech Lists on Nasdaq via SPAC Merger
The cancer-therapy developer completes its SPAC deal with Voyager Acquisition Corp., marking one of the few biotech lis…
The cancer-therapy developer completes its SPAC deal with Voyager Acquisition Corp., marking one of the few biotech lis…
The Baltic seafood group exits its SKT subsidiary as shareholder loans and inventory financing transfer to the Latvian …
Shareholder approval secured in May; deferred payment terms govern the outstanding purchase price and transferred inven…
Phase 3 data for lead asset ecopipam published in JAMA Neurology; regulatory submission targeted for second half of 202…
The bare-bones filing offers no deal terms or acquirer identity, leaving market participants to await further disclosur…
The deal adds scale to Becklar's wholesale monitoring business as demand for critical-event services in food and bevera…
The deal positions 2X as the first firm to unify AI-augmented B2B marketing, sales, and customer success under a single…
Regulatory 8.3 forms signal material shareholding interests as LondonMetric Property and Schroder REIT attract market a…
The submitted document is a UK regulatory Form 8.3 amendment for a real estate investment trust merger with no F&B rele…
Deal adds a battery development platform and a specialist team as distributed energy storage demand rises across food a…
The filing triggers mandatory UK takeover transparency rules but contains no deal terms or premium guidance.
The regulatory filing surfaces as DCC's food and beverage distribution arm remains a closely watched asset among instit…